Purchase Order 36C26126P0508
- Not listed
- Cepheid Inc. has been awarded a delivery order valued at $333,567.56 by the Department of Veterans Affairs' Veterans Integrated Service Network 21 (VISN 21), with a firm fixed-price structure and ultimate completion date of March 15, 2026. This delivery order represents a continuation of the agency's procurement of molecular diagnostic solutions from Cepheid, a Sunnyvale, California-based manufacturer specializing in advanced diagnostic systems and reagents. The award carries no set-aside...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, received a $79,343.96 firm fixed-price purchase order from Veterans Integrated Service Network (VISN) 10 for Cepheid GeneXpert supplies, with a completion date of March 31, 2026. The award, announced on January 1, 2026, represents a standalone purchase order with no set-aside designation and reflects the Department of Veterans Affairs' continued reliance on Cepheid as a primary supplier of diagnostic...
- Cepheid Inc. has been awarded a delivery order valued at $247,262.22 by Veterans Integrated Service Network 9 (VISN 9), a component of the Department of Veterans Affairs, for Cepheid medical equipment reagents to support patient testing. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2026, carries no set-aside designation and represents a continuation of the company's established role as a primary supplier of molecular diagnostic solutions to the VA...
- Cepheid Inc. was awarded a $306,000 firm fixed-price delivery order by the Department of Veterans Affairs' Veterans Integrated Service Network 21 (VISN 21) on October 1, 2025, for the supply of Cepheid testing kits. The contract carries an ultimate completion date of March 31, 2026, with no set-aside designation. As a molecular diagnostics manufacturer headquartered in Sunnyvale, California, Cepheid supplies the federal healthcare system with advanced diagnostic solutions, particularly its...
- Cepheid has been awarded a firm fixed-price delivery order valued at $40,704.72 by the Department of Veterans Affairs' Veterans Integrated Service Network 9 (VISN 9). The contract, with an ultimate completion date of May 31, 2025, is for molecular diagnostic solutions to be delivered and performed in Sunnyvale, California. This delivery order carries no set-aside designation and represents a continuation of Cepheid's ongoing provision of advanced diagnostic systems and testing solutions to the...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a Blanket Purchase Agreement (BPA) call valued at $1.86M on October 1, 2024, by Veterans Integrated Service Network 19 (VISN 19), a civilian agency within the Department of Veterans Affairs. This firm fixed-price contract, with an ultimate completion date of September 30, 2025, covers molecular testing services and diagnostic solutions utilizing Cepheid's GeneXpert diagnostic platform. The award is issued under the General...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $179.7K firm fixed-price purchase order by the Department of Veterans Affairs' Veterans Integrated Service Network 7 (VISN 7) on January 29, 2026, for a GeneXpert IV-4 Site System, with performance to be completed by April 27, 2026. The award carries no set-aside designation, reflecting Cepheid's established competitive position as a primary federal supplier of molecular diagnostic systems and reagents. This purchase order...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a $613,093.80 firm fixed-price purchase order by the Department of Veterans Affairs' Veterans Integrated Service Network 22 (VISN 22) for Cepheid reagents. The contract was awarded on March 1, 2026, with an ultimate completion date of February 28, 2027, and carries no set-aside designation. As a leading supplier of molecular diagnostic solutions to the federal healthcare system, Cepheid will deliver diagnostic reagents and...
- Cepheid Inc., a manufacturer of molecular diagnostic solutions based in Sunnyvale, California, was awarded a purchase order valued at $5.17 million by the Department of Veterans Affairs' Veterans Integrated Service Network 8 on October 1, 2022. This firm fixed-price contract, with no set-aside designation, is a modification to an existing agreement that adjusts clinical quantities based on updated workload estimates for microbiology testing services. The contract calls for an all-inclusive...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $2.27 million firm fixed-price purchase order by the Department of Veterans Affairs through Veterans Integrated Service Network 20 for the lease and purchase of a molecular diagnostic testing system along with instrument-specific assays. The contract, awarded on August 1, 2022, with an ultimate completion date of July 31, 2027, carries no set-aside designation and represents part of the VA's broader reliance on Cepheid as a...
Cepheid Inc. was awarded a firm fixed-price purchase order valued at $24,162 by the Department of Veterans Affairs' Veterans Integrated Service Network 21 (VISN 21) for a GeneXpert service agreement, with performance to be completed by March 15, 2027. The contract was awarded on March 16, 2026, with no set-aside designation, and is to be performed in Reno, Nevada. This award reflects Cepheid's established role as a primary federal supplier of molecular diagnostic solutions to the VA, supporting the department's clinical laboratory operations and infectious disease testing capabilities across its distributed network of medical facilities. This purchase order is part of Cepheid's broader federal contracting portfolio with the VA, which includes two significant Indefinite Delivery Contracts with VISN 17 (valued at $6.7 million through December 2029) and VISN 6 (valued at $32.8 million through September 2030) for GeneXpert diagnostic reagents, test kits, and molecular testing system assays. Cepheid's federal customer base extends beyond the VA to include the Indian Health Service, Defense Health Agency, Defense Logistics Agency, and the U.S. Coast Guard, demonstrating the company's competitive positioning in the federal molecular diagnostics market for infectious disease detection and clinical condition testing.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.2k | 3/11/26 |